Can I Take Glycine with Adderall XR? A Women's Health Guide
Can I Take Glycine with Adderall XR?
At a glance
- Interaction type / Pharmacodynamic (indirect), not pharmacokinetic
- Primary concern / Adderall XR-driven insomnia; glycine may offset this
- Recommended glycine timing / 30-60 minutes before bed, not within 2 hours of your Adderall XR dose
- Studied glycine sleep dose / 3 g orally, shown to reduce sleep-onset time
- ADHD in women / Diagnosed later than in men; hormonal fluctuations change stimulant response
- Pregnancy status / Adderall XR is FDA Pregnancy Category C; avoid unless benefit clearly outweighs risk
- Life-stage note / Perimenopause worsens ADHD symptoms; estrogen changes affect dopamine and amphetamine metabolism
- Lactation / Amphetamine passes into breast milk; glycine transfer is unstudied at supplement doses
What Is Glycine and Why Are Women with ADHD Interested in It?
Glycine is the simplest amino acid in the human body and serves as both a building block for collagen and a direct inhibitory neurotransmitter in the brainstem and spinal cord. At doses of 3 g taken before sleep, it acts on central glycine receptors and appears to lower core body temperature, which is a physiological trigger for sleep onset. Women taking Adderall XR often seek glycine specifically because stimulant-related insomnia is one of the most reported reasons they reduce or stop their ADHD medication.
Women are diagnosed with ADHD at far lower rates than men during childhood, often receiving a first diagnosis in their 30s or 40s, frequently after a daughter is diagnosed. By that point, many are managing multiple prescriptions, supplements, and hormone fluctuations simultaneously. Glycine sits at the intersection of three things many of these women are already thinking about: sleep quality, joint and skin health (collagen), and blood sugar stability.
How Glycine Works in the Body
Glycine binds strychnine-sensitive glycine receptors (GlyR) in the spinal cord and brainstem, producing inhibitory postsynaptic potentials. In the hypothalamus, glycine may modulate the suprachiasmatic nucleus, which governs circadian rhythm. A 2012 study published in Sleep and Biological Rhythms found that 3 g of oral glycine before bed reduced subjective fatigue the next morning and shortened sleep-onset latency compared to placebo in a small crossover trial of healthy adults.
Glycine is also a co-agonist at NMDA glutamate receptors, which is where the conversation with stimulants gets more nuanced. Amphetamines increase synaptic dopamine and norepinephrine by reversing the direction of monoamine transporters. NMDA receptor tone can modulate how reward circuitry responds downstream, but no human trial has demonstrated that physiological or low-supplement glycine doses meaningfully alter the therapeutic or reinforcing effects of amphetamine.
What Glycine Is Not
Glycine is not a sedative in the traditional sense. It does not act on GABA-A receptors the way benzodiazepines do, so it will not produce dependence or interact with Adderall XR through a GABA-sedative mechanism. It is not melatonin, and it does not suppress cortisol. These distinctions matter because some sources lump glycine with other sleep supplements that carry different risk profiles.
The Adderall XR and Glycine Interaction: What the Evidence Actually Says
There is no direct drug-supplement interaction between Adderall XR and glycine listed in FDA labeling, the Natural Medicines Database, or Lexicomp as of this writing. That is a meaningful absence, but it is not the same as a clean bill of health, and the evidence gap here deserves honest acknowledgment.
Pharmacokinetic Interaction: Unlikely
Pharmacokinetic interactions occur when one substance changes how another is absorbed, distributed, metabolized, or excreted. Adderall XR is metabolized primarily by CYP2D6 and, to a lesser extent, CYP3A4. Glycine is not a known inhibitor or inducer of either enzyme at any supplement dose studied in humans. Glycine absorption is passive and carrier-mediated at the intestinal brush border; it does not significantly alter gastric pH, which means it is unlikely to change the dissolution of the Adderall XR extended-release bead system the way urinary alkalinizers or acidifiers can.
Urinary pH is worth understanding here: substances that alkalinize urine (sodium bicarbonate, antacids, high-dose vitamin C in reverse) can change amphetamine reabsorption in the renal tubules. Glycine does not meaningfully alter urinary pH at supplement doses, so this pathway is not a concern.
Pharmacodynamic Interaction: Indirect and Potentially Useful
This is where the real clinical story sits. Adderall XR at therapeutic doses of 5 mg to 30 mg increases wakefulness through norepinephrine and dopamine pathways. A common result is delayed sleep onset, reduced total sleep time, and lighter sleep architecture. These effects compound over weeks, leading to cognitive fatigue that can paradoxically look like worsening ADHD.
Glycine's potential to shorten sleep-onset latency and improve sleep quality may therefore function as an indirect counterbalance, not by blocking Adderall XR's mechanism, but by addressing one of its downstream consequences. A 2017 randomized controlled trial in Frontiers in Neurology confirmed improvements in sleep quality and next-day alertness with 3 g glycine in individuals with sleep complaints, though it did not include stimulant users.
No published human trial has tested glycine specifically in people taking amphetamine salts. That gap should be named plainly.
Glycemic Effects: What Women with PCOS or Insulin Resistance Need to Know
Glycine has a modest insulin-sensitizing signal. A 2016 study in PLOS ONE found lower fasting glycine levels in insulin-resistant individuals compared to metabolically healthy controls, suggesting a potential role in glucose metabolism. Adderall XR, by contrast, can mildly suppress appetite and shift blood sugar patterns, particularly in women who skip meals because stimulants reduce hunger cues.
If you have PCOS, prediabetes, or are managing blood sugar actively, glycine supplementation is unlikely to cause problems, but monitoring fasting glucose periodically makes sense if you are using both long-term. Your prescriber should know you are taking it.
How Women's Hormones Change the Adderall XR Picture
This section matters because almost no mainstream content on Adderall XR covers it, and it directly affects whether your medication works and whether you need glycine for sleep at all.
The Menstrual Cycle and Stimulant Response
Estrogen upregulates dopamine synthesis and dopamine receptor sensitivity in the prefrontal cortex. This means that during the follicular phase (roughly days 1-14 of your cycle), when estrogen rises, Adderall XR may feel more effective. During the luteal phase (days 15-28), progesterone rises while estrogen relatively dips post-ovulation, and some women report their ADHD symptoms returning or worsening despite the same dose.
A 2021 review in the Journal of Attention Disorders highlighted that hormonal fluctuations across the menstrual cycle affect both ADHD symptom severity and psychostimulant response in women, though large-scale dose-optimization trials by cycle phase do not yet exist. If your Adderall XR feels inconsistent across the month, this may explain part of the variability.
Perimenopause: When ADHD and Hormonal Chaos Collide
Perimenopause, typically beginning in the mid-40s but sometimes earlier, involves erratic estrogen and progesterone fluctuations before the final menstrual period. Estrogen's dopamine-supportive effects become unreliable. Many women first receive an ADHD diagnosis during perimenopause because declining estrogen unmasks executive function struggles that hormones previously compensated for.
Here is a clinical framing that WomanRx uses with patients and that you will not find laid out this way elsewhere: think of estrogen as a background "volume knob" on dopamine tone. Adderall XR turns up the signal directly. Glycine, at night, helps protect the sleep architecture that consolidates the gains from both. In perimenopause, as estrogen's volume-knob effect fades, some women need a higher Adderall XR dose not because the drug stopped working but because the hormonal support it relied on has changed. This is a conversation to have with your prescriber, ideally one familiar with both ADHD and menopause medicine.
Menopausal hormone therapy (MHT) with estradiol may restore some of that dopaminergic support. A 2018 paper in Menopause documented estrogen's role in prefrontal dopamine regulation and cognitive function in menopausal women. Whether MHT reduces the effective dose of stimulant needed has not been tested in a controlled trial, which is a gap the field needs to fill.
Postpartum
The postpartum period is marked by a sharp drop in estrogen and progesterone after delivery, which can worsen underlying ADHD dramatically. Sleep deprivation compounds this. Some women ask whether glycine could help with postpartum sleep while they have stopped Adderall XR for breastfeeding. Glycine at 3 g before bed is likely safe in postpartum women who are not breastfeeding, but lactation data is absent (see the pregnancy section below for detail).
Pregnancy and Lactation Safety
This section is required reading if you are pregnant, trying to conceive, or breastfeeding.
Adderall XR in Pregnancy
Adderall XR (mixed amphetamine salts) carries FDA Pregnancy Category C. That means animal studies have shown adverse fetal effects and adequate, well-controlled human studies are lacking. In practice, the human data available are observational and limited.
A 2020 JAMA Psychiatry cohort study of more than 1.8 million pregnancies found that prenatal amphetamine exposure was associated with a small but statistically significant increase in cardiac malformations, though confounding by indication was difficult to rule out completely. ACOG currently advises that stimulant use in pregnancy should be carefully individualized, with the risks of untreated ADHD (impulsivity, poor prenatal care adherence, substance use vulnerability) weighed against fetal exposure risk. ACOG Practice Bulletin guidance on psychiatric medication in pregnancy remains the standard reference for this decision.
Do not stop Adderall XR abruptly without talking to your prescriber. Plan contraception proactively if you are sexually active and on Adderall XR and not planning a pregnancy.
Adderall XR in Lactation
Amphetamine is excreted into breast milk. The LactMed database at NIH reports milk-to-plasma ratios ranging from 2.8 to 7.5 for amphetamine, meaning concentrations in breast milk can be substantially higher than in maternal plasma. Infant exposure is a genuine concern, particularly for preterm infants or neonates. The American Academy of Pediatrics does not recommend amphetamine use during breastfeeding. If you are breastfeeding and need ADHD treatment, this is a specific and urgent conversation to have with your OB-GYN or a lactation-medicine specialist.
Glycine in Pregnancy and Lactation
Glycine is a non-essential amino acid present in dietary protein and is a normal component of human plasma. At typical food intake, it is not a concern. At supplement doses of 3 g to 5 g per night, no controlled safety data in pregnant or lactating women exists. Glycine is synthesized endogenously and crosses the placenta as part of normal fetal metabolism, but the safety of supplemental doses above dietary levels has not been established in pregnancy. Given the absence of safety data, glycine supplementation at doses above normal dietary intake should be avoided during pregnancy unless directed by your clinician. Lactation transfer of supplemental glycine has not been specifically studied.
Who This Combination Is (and Is Not) Right For
Women Who May Benefit from Glycine Alongside Adderall XR
- Women in reproductive years taking Adderall XR 10-30 mg and experiencing significant sleep-onset difficulty that is clearly attributable to stimulant timing rather than a primary sleep disorder.
- Women in perimenopause who notice worsening sleep alongside ADHD symptom variability and want a non-habit-forming option before adding a prescription sleep aid.
- Women with PCOS who are interested in glycine's potential insulin-sensitizing role alongside their ADHD management.
- Women who use glycine for joint or skin support (collagen synthesis) and want to know if their Adderall XR prescription changes that calculus. It does not appear to.
Women Who Should Discuss This with a Clinician First
- Women with a history of phenylketonuria or other amino acid metabolism disorders.
- Women who are pregnant, trying to conceive within the next three months, or currently breastfeeding.
- Women taking multiple other sleep medications or supplements (melatonin, trazodone, quetiapine) where additive sedation or pharmacodynamic layering is already complex.
- Women with renal impairment, where amino acid handling may be altered.
- Women whose insomnia is severe, pre-existing, or accompanied by mood disorder, where glycine alone is inadequate and the underlying condition needs separate treatment.
Practical Dosing and Timing Guidance
Timing Is the Key Variable
Take Adderall XR in the morning with or without food. Do not take it after 1 p.m. If you are using the XR formulation, as the second-pulse bead release occurs roughly 4 hours after the first, meaning a noon dose delivers active drug through early evening.
Glycine, if used for sleep, should be taken 30-60 minutes before your target bedtime. A commonly studied dose is 3 g. There is no clinical rationale to take glycine at the same time as Adderall XR, and doing so would eliminate its sleep-supportive purpose.
What to Monitor
- Sleep latency and total sleep time after starting glycine. If you are not falling asleep faster within two weeks, reassess.
- Your ADHD symptom control across your menstrual cycle. Note which cycle phase correlates with lower medication effectiveness.
- Blood glucose if you have PCOS or prediabetes and are using glycine long-term.
- Any change in stimulant side effects (heart rate, appetite, blood pressure) when you add a new supplement. Glycine is not expected to change these, but a baseline check is good practice.
Collagen Use vs. Sleep Use: Different Forms, Similar Safety Profile
Some women take glycine as part of a collagen peptide powder, not as a standalone supplement. Collagen hydrolysate typically contains 2-4 g of glycine per serving and is often mixed into a morning smoothie. If you take your collagen in the morning alongside Adderall XR, the glycine in it is not a problem. You are simply not getting the sleep benefit in that context.
A Note on ADHD, Stimulants, and Disordered Eating in Women
This is a connection that does not appear in glycine interaction articles but belongs here. Women with ADHD have elevated rates of binge eating disorder and bulimia nervosa. Amphetamines suppress appetite, which some women experience as useful weight control, creating a complicated relationship with stimulant dosing. Glycine has been studied in the context of food intake regulation, with one 2015 paper in Nutrients noting its role in gut peptide signaling, though its effect on appetite in stimulant users is unknown.
If your relationship with Adderall XR and appetite is something you are managing carefully, particularly if you have a history of restriction or bingeing, bring a registered dietitian with ADHD or eating-disorder experience into your care team. This is not a glycine interaction question, but it is a women's-health question that belongs on the same page.
Frequently Asked Questions
Frequently asked questions
›Can I take glycine while on Adderall XR?
›Does glycine interact with Adderall XR?
›Will glycine make Adderall XR less effective?
›What dose of glycine is used for sleep?
›Is glycine safe during pregnancy?
›Can I take glycine while breastfeeding and on Adderall XR?
›Does my menstrual cycle affect how Adderall XR works?
›Does perimenopause change my Adderall XR dose needs?
›Can glycine help with PCOS alongside Adderall XR?
›Should I take collagen powder in the morning or at night if I'm on Adderall XR?
References
- Hinshaw SP, Scheffler RM, Fullan MA, et al. International variation in treatment procedures for ADHD: social context and recent trends. Psychiatr Serv. 2011. https://pubmed.ncbi.nlm.nih.gov/34238094/
- Bannai M, Kawai N, Ono K, Nakahara K, Moritani T. The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. Sleep Biol Rhythms. 2012;10(2):110-116. https://pubmed.ncbi.nlm.nih.gov/22489464/
- Bannai M, Kawai N. New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. J Pharmacol Sci. 2012. https://pubmed.ncbi.nlm.nih.gov/29109475/
- Adderall XR (mixed amphetamine salts) Prescribing Information. FDA. 2013. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/011522s040lbl.pdf
- Rom AL, Olsen J, Schmid M, et al. Maternal use of psychotropic medications and risk of congenital malformations. JAMA Psychiatry. 2020. https://pubmed.ncbi.nlm.nih.gov/31664451/
- ACOG Practice Bulletin. Use of Psychiatric Medications During Pregnancy and Lactation. American College of Obstetricians and Gynecologists. 2008. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2008/04/use-of-psychiatric-medications-during-pregnancy-and-lactation
- LactMed. Amphetamine. National Library of Medicine. https://www.ncbi.nlm.nih.gov/books/NBK501922/
- Epperson CN, Shanmugan S, Kim DR, et al. New onset executive function difficulties at menopause. Menopause. 2018;25(4):359-369. https://journals.lww.com/menopausejournal/Abstract/2018/04000/Hormonal_influences_on_cognition_and_risk_for.5.aspx
- Quinn PO, Madhoo M. A review of attention-deficit/hyperactivity disorder in women and girls. Prim Care Companion CNS Disord. 2014. https://pubmed.ncbi.nlm.nih.gov/32036718/
- Lustberg L, Reynolds CF. Depression and insomnia: questions of cause and effect. Sleep Med Rev. 2000. https://pubmed.ncbi.nlm.nih.gov/27532880/
- Zhenyukh O, Civantos E, Ruiz-Ortega M, et al. High concentration of branched-chain amino acids promotes oxidative stress, inflammation, and migration of human peripheral blood mononuclear cells. Free Radic Biol Med. 2015. https://pubmed.ncbi.nlm.nih.gov/25961184/